COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,189 Articles (22,198 medRxiv, 7,991 bioRxiv)

Most recent first Previous |  Page 2747: Articles 27461-27470  | Next

Complexity in SARS-CoV-2 genome data: Price theory of mutant isolates
Mandal, S., Singh, R. K. S., Sharma, S. K., Malik, M. Z., Singh, R. K. B.
10.1101/2020.05.04.077511 — Posted: 2020-05-04
Pathogen Reduction Of SARS-CoV-2 Virus In Plasma And Whole Blood Using Riboflavin And UV Light
Ragan, I., Hartson, L., Pidcoke, H., Bowen, R., Goodrich, R. P.
10.1101/2020.05.03.074971 — Posted: 2020-05-04
The UCSC SARS-CoV-2 Genome Browser
Fernandes, J. D., Hinrichs, A. S., Clawson, H., Navarro Gonzales, J., Lee, B. T., Nassar, L. R., Raney, B. J., Rosenbloom, K. R., Nerli, S., Rao, A. A., Schmelter, D., Zweig, A. S., Lowe, T. M., Ares, M., Corbett-Detig, R., Kent, W. J., Haussler, D., Haeussler, M.
10.1101/2020.05.04.075945 — Posted: 2020-05-04
Missense variants in ACE2 are predicted to encourage and inhibit interaction with SARS-CoV-2 Spike and contribute to genetic risk in COVID-19
MacGowan, S. A., Barton, G. J.
10.1101/2020.05.03.074781 — Posted: 2020-05-04
Catalytic cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease
Günther, S., Reinke, P. Y., Oberthuer, D., Yefanov, O., Ginn, H., Meier, S., Lane, T. J., Lorenzen, K., Gelisio, L., Brehm, W., Dunkel, I., Domaracky, M., Saouane, S., Lieske, J., Ehrt, C., Koua, F., Tolstikova, A., White, T. A., Groessler, M., Fleckenstein, H., Trost, F., Galchenkova, M., Gevorkov, Y., Li, C., Awel, S., Peck, A., Xavier, P. L., Barthelmess, M., Schlünzen, F., Werner, N., Andaleeb, H., Ullah, N., Falke, S., Franca, B. A., Schwinzer, M., Brognaro, H., Seychell, B., Gieseler, H., Melo, D., Zaitsev-Doyle, J. J., Norton-Baker, B., Knoska, J., Esperanza, G., Mashhour, A. R., Guicking, F., Hennicke, V., Fischer, P., Rogers, C., Monteiro, D. C., Hakanpää, J., Meyer, J., Noei, H., Gribbon, P., Ellinger, B., Kuzikov, M., Wolf, M., Zhang, L., Sun, X., Pletzer-Zelgert, J., Wollenhaupt, J., Feiler, C., Weiss, M., Schulz, E., Mehrabi, P., Schmidt, C., Schubert, R., Han, H., Krichel, B., Fernández-García, Y., Escudero-Pérez, B., Günther, S., Turk, D., Uetrecht, C., Beck, T., Tidow, H., Chari, A., Zaliani, A., Rarey, M., Cox, R., Hilgenfeld, R., Chapman, H. N., Pearson, A. R., Betzel, C., Meents, A.
10.1101/2020.05.02.043554 — Posted: 2020-05-04
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Vuong, W., Khan, M. B., Fischer, C., Arutyunova, E., Lamer, T., Shields, J., Saffran, H. A., McKay, R. T., van Belkum, M. J., Joyce, M., Young, H. S., Tyrrell, D. L., Vederas, J. C., Lemieux, M. J.
10.1101/2020.05.03.073080 — Posted: 2020-05-04 Discussion: Onsite
Structure of anxiety associated with the COVID-19 pandemic in the Russian-speaking sample: results from on-line survey
Sorokin, M. Y., Kasyanov, E. D., Rukavishnikov, G. V., Makarevich, O. V., Neznanov, N. G., Lutova, N. B., Mazo, G. E.
10.1101/2020.04.28.20074302 — Posted: 2020-05-04
Development and validation of direct RT-LAMP for SARS-CoV-2
Mohon, A. N., Hundt, J., van Marle, G., Pabbaraju, K., Berenger, B., Griener, T., Lisboa, L., Church, D., Czub, M., Greninger, A., Jerome, K., Doolan, C., Pillai, D. R.
10.1101/2020.04.29.20075747 — Posted: 2020-05-04
A cohort of patients with COVID-19 in a major teaching hospital in Europe
Borobia, A. M., Carcas, A. J., Arnalich, F., Alvarez-Sala, R., Montserrat, J., Quintana, M., Figueira, J. C., Torres Santos-Olmo, R. M., Garcia-Rodriguez, J., Martin-Vega, A., Ramirez, E., Buno, A., Martinez-Ales, G., Garcia-Arenzana, N., Marti de Gracia, M., Moreno, F., Reinoso-Barbero, F., Martin-Quiros, A., Rivera, A., Mingorance, J., Carpio, C. C., Prieto Arribas, D., Rey Cuevas, E., Prados, M. C., Rios, J. J., Hernan, M., Frias, J., Arribas, J. R., COVID@HULP working team
10.1101/2020.04.29.20080853 — Posted: 2020-05-04 Discussion: Onsite
A national prospective cohort study of SARS/COV2 pandemic outcomes in the U.S.: The CHASING COVID Cohort
Robertson, M., Kulkarni, S., Berry, A., Mirzayi, C., Maroko, A. R., Zimba, R., Westmoreland, D., Grov, C., Parcesepe, A., Waldron, L., Nash, D.
10.1101/2020.04.28.20080630 — Posted: 2020-05-04 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).